Form 4: Madrigal Pharmaceuticals Director Fred B. Craves Reports Stock and Option Transactions

Director Fred B. Craves reports acquisition of restricted stock units and stock options in Madrigal Pharmaceuticals, along with adjustments to indirectly held shares.

Summary

• Fred B. Craves, a director of Madrigal Pharmaceuticals, filed a Form 4 detailing changes in his beneficial ownership.
• On June 25, 2024, Craves acquired 714 shares of common stock through a grant of restricted stock units, vesting on June 25, 2025, if he remains in service with the Issuer.
• He also acquired 1,105 stock options with an exercise price of $280.04, vesting 100% on the first anniversary of the grant date, provided he continues to serve as a director.
• Craves indirectly holds 11,210 shares through a grantor retained annuity trust, 1,261 shares through Bay City Capital LLC, and 18,000 shares through the Craves Family Foundation.
• Craves disclaims beneficial ownership of the shares held by Bay City Capital LLC, except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock and option grants, indicating standard compensation practices. There's no explicit positive or negative information about the company's performance.

Positives

• The acquisition of restricted stock units and stock options by a director signals confidence in the company's future performance.
• The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Future Outlook

The vesting of restricted stock units and stock options is contingent upon continued service, indicating an expectation of ongoing involvement and commitment from the director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transactions reported in the Form 4 provide transparency to shareholders regarding the director's holdings and incentives.
• The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Key Dates